Generative AI for drug discovery Redesign Science leverages generative AI technology for drug discovery, creating new opportunities for pharmaceutical collaborations and partnerships.
Recent major funding rounds With recent funding rounds totaling $15 million, Redesign Science is in a strong financial position, indicating potential for sales growth and expansion.
Focus on small molecule therapeutics The company's focus on developing small molecule therapeutics presents opportunities for pharmaceutical companies looking to enhance their drug portfolio with innovative solutions.
Investments from prominent venture capitalists High-profile investments from venture capitalists like Third Kind Venture Capital, ZhenFund, and Preface Ventures signal confidence in Redesign Science's potential, making it an attractive partner for collaborations.
Competitive landscape and market positioning By analyzing similar companies like Cyclica, insitro, and Atomwise, Redesign Science can identify market trends and competitive positioning to tailor its sales strategy for better traction in the industry.
51
$10M$50M
327$50M$100M
51$10M$50M
54$10M$50M
85$10M$50M
246$10M$50M
25$10M
102$10M$50M
18$10MRedesign Science uses 8 technology products and services including Cloudflare CDN, Google Font API, jQuery, and more. Explore Redesign Science's tech stack below.
| Redesign Science Email Formats | Percentage |
| First@redesignscience.com | 47% |
| First.Last@redesignscience.com | 5% |
| Last@redesignscience.com | 1% |
| First@redesignscience.com | 47% |
Biotechnology ResearchNew York, United States11-50 Employees
Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.
Company Overview
Media & News
Funding & FinancialsRedesign Science has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Dec 08, 2021 in the amount of $15M.
Redesign Science's revenue is in the range of $10M
Funding & FinancialsRedesign Science has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Dec 08, 2021 in the amount of $15M.
Redesign Science's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com